Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pharma M&A Feeding Frenzy Set To Continue As Investors Ask 'Who's Next?'

This article was originally published in Scrip

Executive Summary

A decade-long M&A cycle has hit a high point with Pfizer Inc.'s plan to devour Allergan PLC and the consolidation trend looks set to continue amid bullish investor sentiment, with most activity likely to be in the area of mid-sized branded drug makers, analysts say.

Advertisement
Advertisement
UsernamePublicRestriction

Register